Evidence map›Paper›PMID 40904369›Full record

ArticleFrontiers in medicine2025

Case Report: The Alzheimer's paradox: a clinically stable amnestic syndrome with full biomarker positivity and minimal imaging evidence.

Anna-Chloé Balageas, Johnny Vercouillie, Nicolas Arlicot, Anne-Claire Dupont, Maria-Joao Santiago Ribeiro

Abstract readCase Reports
In one paragraph

Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Anna-Chloé BalageasCentre Mémoire Ressources et Recherche CHU Tours, Tours, France.
Johnny VercouillieUMR, iBrain, Université de Tours, Inserm, Tours, France.
Nicolas ArlicotUMR, iBrain, Université de Tours, Inserm, Tours, France.
Anne-Claire DupontRadiopharmacy, CHU Tours, Tours, France.
Maria-Joao Santiago RibeiroUMR, iBrain, Université de Tours, Inserm, Tours, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We report the case of a 75-year-old patient with a clinically isolated and stable amnestic syndrome over fifteen years, despite a cerebrospinal fluid (CSF) profile strongly consistent with Alzheimer's disease (AD). Serial PET imaging over two years showed only limited amyloid accumulation, no significant tau deposition, no hypometabolism, and no neuroinflammation. This case illustrates a striking dissociation between biomarker positivity and clinical progression, raising important questions about individual resilience and the prognostic value of AD biomarkers in isolation.

Indexed as

AlzheimerbiomarkerMCIneuroimagingPET imaging

Identifiers

PMID40904369
PMCPMC12401901

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.